| Financier | Commitments |
|---|---|
| Pandemic Emergency Financing Facility | 0.94 |
| Health Emergency Preparedness and Response Multi-Donor Trust | 3.50 |
| IDA Grant | 5.50 |
STP COVID-19 Emergency Response Project
Abstract*
After the emergence of the new coronavirus, called COVID-19, in China and its spread outside China, on January 30, 2020, the Director-General of the World Health Organization (WHO) declared COVID-19 as a public health emergency of international concern (PHEIC), based on the opinion of the International Emergency Committee and within the framework of the International Health Regulations (2005). This Declaration implies that all countries must increase... Show More
Development Objective
to prevent, detect and respond to the threat posed by COVID-19, strengthen national systems for public health preparedness in the Recipient’s territory, and in case of an Eligible Crisis or Emergency, respond promptly and effectively to it.
Key Details
Project Details
P173783
Active
Humberto Cossa , Renzo Sotomayor Noel
Democratic Republic of Sao Tome
March 25, 2020
(as of board presentation)
April 2, 2020
April 6, 2020
US$ 2.50 million
Ministry of Health
2020
US$ 9.94 million
N/A
Substantial
June 30, 2025
No
BANK APPROVED
June 13, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 5.50 |
| IBRD + IDA Commitment | 5.50 |
| Lending Instrument | |
|---|---|
| Grant Amount | 4.44 |
| Total Project Cost** | 2.50 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Jun 9, 2020 | IDA-D6060 | Loan Disb | 18,050.65 |
| Jun 25, 2020 | IDA-D6060 | Loan Disb | 29,909.00 |
| Nov 4, 2020 | IDA-D6060 | Loan Disb | 109,200.00 |
| Jul 15, 2020 | IDA-D6060 | Loan Disb | 144,410.95 |
| Jun 14, 2023 | IDA-D8130 | Loan Disb | 39,027.40 |
| Feb 2, 2024 | IDA-D8130 | Loan Disb | 26,350.08 |
| Jul 5, 2024 | IDA-E2230 | Loan Disb | 26,218.15 |
| May 1, 2024 | IDA-E2230 | Loan Disb | 400,000.00 |
| Mar 20, 2024 | IDA-D8130 | Loan Disb | -262,271.97 |
| Jul 2, 2024 | IDA-E2230 | Loan Disb | 28,068.16 |
| Jul 18, 2024 | IDA-E2230 | Loan Disb | 400,000.00 |
| Apr 2, 2020 | IDA-D6060 | Loan Commitment | 2,500,000.00 |
| May 13, 2021 | IDA-D8130 | Loan Commitment | 3,000,000.00 |
| Aug 31, 2023 | IDA-E2230 | Loan Commitment | 1,500,000.00 |
| Dec 8, 2022 | IDA-D8130 | Loan Disb | 20,356.19 |
| Dec 6, 2022 | IDA-D8130 | Loan Disb | 15,727.94 |
| Dec 6, 2022 | IDA-D8130 | Loan Disb | 14,914.10 |
| Dec 6, 2022 | IDA-D6060 | Loan Disb | 10,300.01 |
| Sep 29, 2022 | IDA-D6060 | Loan Disb | 36,307.62 |
| Sep 27, 2022 | IDA-D8130 | Loan Disb | 8,679.67 |
| May 4, 2023 | IDA-D8130 | Loan Disb | 22,678.77 |
| Feb 16, 2023 | IDA-D8130 | Loan Disb | 114,550.99 |
| Aug 25, 2023 | IDA-D8130 | Loan Disb | 27,687.46 |
| Jul 20, 2023 | IDA-D8130 | Loan Disb | 19,413.20 |
| Dec 19, 2023 | IDA-D8130 | Loan Disb | 11,589.91 |
| Nov 28, 2023 | IDA-D8130 | Loan Disb | 92,442.01 |
| Nov 29, 2021 | IDA-D8130 | Loan Disb | 9,411.95 |
| Jun 15, 2022 | IDA-D8130 | Loan Disb | 15,167.33 |
| Sep 29, 2021 | IDA-D8130 | Loan Disb | 300,459.84 |
| Nov 1, 2021 | IDA-D8130 | Loan Disb | 577,368.00 |
| Nov 1, 2021 | IDA-D8130 | Loan Disb | 120,000.00 |
| Jun 21, 2022 | IDA-D6060 | Loan Disb | 17,585.73 |
| Jun 21, 2022 | IDA-D8130 | Loan Disb | 15,858.02 |
| Jul 15, 2022 | IDA-D8130 | Loan Disb | 15,288.75 |
| Feb 2, 2022 | IDA-D8130 | Loan Disb | 30,027.89 |
| Jan 26, 2022 | IDA-D8130 | Loan Disb | 604,800.00 |
| Jun 22, 2022 | IDA-D6060 | Loan Disb | 42,431.56 |
| Jun 17, 2022 | IDA-D8130 | Loan Disb | 65,644.80 |
| Feb 2, 2022 | IDA-D6060 | Loan Disb | 64,439.66 |
| Oct 27, 2020 | IDA-D6060 | Loan Disb | 19,941.01 |
| Oct 27, 2020 | IDA-D6060 | Loan Disb | 73,176.97 |
| Aug 3, 2020 | IDA-D6060 | Loan Disb | 20,056.13 |
| Apr 15, 2020 | IDA-D6060 | Loan Disb | 200,000.00 |
| Dec 3, 2020 | IDA-D6060 | Loan Disb | 151,719.45 |
| Sep 23, 2020 | IDA-D6060 | Loan Disb | 602,000.00 |
| May 21, 2020 | IDA-D6060 | Loan Disb | 155,914.45 |
| Jul 23, 2020 | IDA-D6060 | Loan Disb | 136,903.60 |
| Jun 7, 2021 | IDA-D6060 | Loan Disb | 7,293.90 |
| Jul 29, 2021 | IDA-D6060 | Loan Disb | 131,787.36 |
| Dec 9, 2020 | IDA-D6060 | Loan Disb | 170,534.39 |
| Aug 5, 2020 | IDA-D6060 | Loan Disb | 17,049.23 |
| May 27, 2021 | IDA-D6060 | Loan Disb | 78,857.66 |
| Jul 16, 2021 | IDA-D6060 | Loan Disb | 188,841.56 |
| Sep 10, 2021 | IDA-D8130 | Loan Disb | -179,999.98 |
| Jun 4, 2021 | IDA-D6060 | Loan Disb | -20,014.01 |
| Apr 9, 2021 | IDA-D6060 | Loan Disb | 52,667.04 |
| Jun 23, 2021 | IDA-D6060 | Loan Disb | 68,336.15 |
| Mar 11, 2022 | IDA-D6060 | Loan Disb | 57,370.58 |
| Mar 11, 2022 | IDA-D8130 | Loan Disb | 27,679.72 |
| Jul 15, 2022 | IDA-D6060 | Loan Disb | 45,196.05 |
| Apr 20, 2022 | IDA-D8130 | Loan Disb | 39,827.80 |
| Apr 20, 2022 | IDA-D6060 | Loan Disb | 30,980.74 |
| Sep 27, 2021 | IDA-D8130 | Loan Disb | 180,000.00 |
| Aug 17, 2021 | IDA-D8130 | Loan Disb | 180,000.00 |
| Aug 17, 2021 | IDA-D8130 | Loan Disb | 200,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Monitoring and Evaluation | Satisfactory | 2024-12-23 |
| Progress towards achievement of PDO | Satisfactory | 2024-12-23 |
| Procurement | Satisfactory | 2024-12-23 |
| Financial Management | Moderately Satisfactory | 2024-12-23 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-12-23 |
| Project Management | Satisfactory | 2024-12-23 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Country adopted personal and community non-pharmaceutical interventions (school closures, telework and remote meetings, reduce/cancel mass gatherings) Value 0.00 100.00 85.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan [disaggregated by sex] Value 0.00 90.00 90.00 Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Country has activated their public health Emergency Operations Center or a coordination mechanism for COVID-19 Value No Yes Yes Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Percentage of acute healthcare facilities with isolation capacity Value 0.00 100.00 60.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment M&E system established to monitor COVID-19 preparedness and response plan Value No Yes Yes Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Percentage of suspected cases of dengue that were investigated, laboratory confirmed, and reported, based on National Guidelines Value 0.00 70.00 70.00 Date July 12, 2023 November 27, 2023 June 30, 2025 Comment Percentage of suspected cases of COVID-19 cases that were investigated, laboratory confirmed and reported based on national guidelines; Value 0.00 100.00 90.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
At least one multi- sectoral simulation exercise conducted by the EOC with results incorporated into national COVID-19 preparednessand response plans Value 0.00 3.00 2.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Number of health staff trained in infection prevention and control per MOH-approved protocols (disaggregated by sex) Value 0.00 1345.00 1345.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Percentage of monthly and quarterly project M&E reports submitted on time Value 0.00 100.00 70.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Laboratory Capacity to identify dengue serotypes Value No No Yes Date July 12, 2023 May 30, 2024 June 30, 2025 Comment At least two meetings per year of an intersectoral committee on One Health (MoH, Ministry of Agriculture, Ministry of Environment) to ensure strengthened surveillance in the human-health-environment Value 0.00 4.00 4.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Country has prepared a referral system to care for COVID-19 patients Value No Yes Yes Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Number of annual progress reports submitted complete and on time Value 0.00 3.00 2.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Campaign to sensitize the public to adopt behaviors for the control of dengue and other vector transmitted diseases Value 0.00 7.00 7.00 Date July 12, 2023 May 30, 2024 June 30, 2025 Comment Number of designated laboratories with staff trained to conduct COVID-19 diagnosis Value 0.00 9.00 3.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Percentage of eligible households provided with food and basic supplies within quarantined populations Value 0.00 100.00 80.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Number of refurbished/upgraded health facilities implementing customer satisfaction survey Value 0.00 23.00 20.00 Date March 27, 2020 May 30, 2024 June 30, 2025 Comment Community Health workers trained in event based surveillance for COVID-19 and other epidemic-prone diseases (disaggregated by sex) Value 0.00 110.00 110.00 Date August 21, 2020 May 30, 2024 June 30, 2025 Comment Laboratory technicians trained on COVID19 diagnosis as well as in 5 key priority diseases as per the IHR (2005) (disaggregated by sex) Value 0.00 18.00 10.00 Date August 21, 2020 May 30, 2024 June 30, 2025 Comment Percentage of PHC facilities implementing exit surveys in a one-year period, present to MOH, and implement action plan to address issues as part of Project Operational Plan Value 0.00 100.00 100.00 Date August 21, 2020 May 30, 2024 June 30, 2025 Comment A National Deployment and Vaccination Plan (NDVP) implemented with input from relevant bodies (Text) Value No Yes Yes Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Vaccine stock management tools and operating procedures updated to reflect the characteristics of COVID-19 vaccines. Value No Yes Yes Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Effective Vaccine Management assessments implemented with composite scores of 80% or higher (Text) Value No Yes Yes Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Community engagement plan implemented for increasing demand creation for the Covid-19 vaccine by the population Value No Yes Yes Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Pharmacovigilance System (PVS) adapted to detect Adverse Events Following Vaccination (AEFI) for the COVID-19 vaccine Value No Yes Yes Date February 8, 2021 May 30, 2024 June 30, 2025 Comment Number of eligible health facilities with improved operational cooling and refrigeration equipment financed by the Project Value 0.00 0.00 10.00 Date July 12, 2023 May 30, 2024 June 30, 2025 Comment Solar capacity installed at health facilities supported by the project Value 0.00 0.00 0.06 Date July 12, 2023 May 30, 2024 June 30, 2025 Comment